152 related articles for article (PubMed ID: 19112424)
1. Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells.
Ohbayashi M; Yasuda M; Kawakami I; Kohyama N; Kobayashi Y; Yamamoto T
Exp Oncol; 2008 Dec; 30(4):276-82. PubMed ID: 19112424
[TBL] [Abstract][Full Text] [Related]
2. Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Cordes N; Beinke C; Plasswilm L; van Beuningen D
Strahlenther Onkol; 2004 Mar; 180(3):157-64. PubMed ID: 14991204
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs.
Dunn SE; Hardman RA; Kari FW; Barrett JC
Cancer Res; 1997 Jul; 57(13):2687-93. PubMed ID: 9205078
[TBL] [Abstract][Full Text] [Related]
4. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells.
Underwood PA; Bennett FA
Exp Cell Res; 1993 Apr; 205(2):311-9. PubMed ID: 7683271
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of integrins in adriamycin-resistant human breast cancer cells.
Narita T; Kimura N; Sato M; Matsuura N; Kannagi R
Anticancer Res; 1998; 18(1A):257-62. PubMed ID: 9568087
[TBL] [Abstract][Full Text] [Related]
6. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
8. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
9. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
Vadgama JV; Wu Y; Shen D; Hsia S; Block J
Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
11. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
Stoika RS; Yakymovych IA; Kashchak NI; Boyko MM; Korynevska AV; Klyuchyvska OY; Shafranska GI; Yakymovych MY; Zhylchuk VY; Kudryavets YY; Vorontsova AL
Exp Oncol; 2008 Mar; 30(1):35-41. PubMed ID: 18438339
[TBL] [Abstract][Full Text] [Related]
12. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
14. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.
Bérubé M; Talbot M; Collin C; Paquet-Bouchard C; Germain L; Guérin SL; Petitclerc E
Int J Oncol; 2005 Feb; 26(2):405-13. PubMed ID: 15645125
[TBL] [Abstract][Full Text] [Related]
15. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
[TBL] [Abstract][Full Text] [Related]
16. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
Haier J; Nasralla M; Nicolson GL
Br J Cancer; 1999 Aug; 80(12):1867-74. PubMed ID: 10471033
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells.
Xie JW; Haslam SZ
Breast Cancer Res Treat; 2008 Jul; 110(2):257-68. PubMed ID: 17851761
[TBL] [Abstract][Full Text] [Related]
18. A tumor derived motility factor that stimulates cell migration on extracellular matrix.
Klominek J; Robért KH; Sundqvist KG
Anticancer Res; 1998; 18(3A):1601-12. PubMed ID: 9673377
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
20. Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells.
Chen G; Teicher BA; Frei E
Anticancer Res; 1996; 16(6B):3499-505. PubMed ID: 9042212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
